Ignite Creation Date:
2024-05-05 @ 10:58 PM
Last Modification Date:
2024-10-26 @ 10:26 AM
Study NCT ID:
NCT01223027
Status:
COMPLETED
Last Update Posted:
2015-12-07
First Post:
2010-09-30
Brief Title:
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis